# clm_2315D6C49C3A

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cash_and_equivalents  
value: 1,437,900,000 United States dollar  
valid_from: 2021-03-31  
valid_to: 2021-06-30  
published: 2021-05-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C7438CFA174A  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals cash and equivalents: 1,437,900,000 United States dollar", as of 2021-03-31 (until 2021-06-30). Claim clm_2315D6C49C3A, https://asof.is/claim/clm_2315D6C49C3A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-05-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2021, published 2021-05-06)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,193,700,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_2315D6C49C3A](/claim/clm_2315D6C49C3A.md) | [clm_DC54DFD6D27B](/claim/clm_DC54DFD6D27B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.